{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:11:59Z","timestamp":1790885519271,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.bcp.2005.03.034","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T11:20:07Z","timestamp":1117106407000},"page":"144-151","source":"Crossref","is-referenced-by-count":14,"title":["Limited protective role of V-PYRRO\/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice"],"prefix":"10.1016","volume":"70","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin F.","family":"Chignell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Waalkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2005.03.034_bib1","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/jm9701031","article-title":"Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver","volume":"40","author":"Saavedra","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2005.03.034_bib2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/jhep.2000.18291","article-title":"Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8","volume":"32","author":"Kim","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2005.03.034_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.300.1.18","article-title":"O(2)-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against d-galactosamine\/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays","volume":"300","author":"Liu","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2005.03.034_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/jhep.2003.50063","article-title":"The nitric oxide donor, V-PYRRO\/NO, protects against acetaminophen-induced hepatotoxicity in mice","volume":"37","author":"Liu","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2005.03.034_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.103.065003","article-title":"The nitric oxide donor, O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO\/NO), protects against cadmium-induced hepatotoxicity in mice","volume":"310","author":"Liu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2005.03.034_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00007890-200101270-00004","article-title":"V-PYRRO\/NO: an hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion","volume":"71","author":"Ricciardi","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bcp.2005.03.034_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/jhep.2002.35533","article-title":"Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats","volume":"36","author":"Moal","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2005.03.034_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.1840380416","article-title":"Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome","volume":"38","author":"DeLeve","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2005.03.034_bib9","first-page":"208","article-title":"Nitric oxide and chemically induced hepatotoxicity: beneficial effects of the liver-selective nitric oxide donor, V-PYRRO\/NO","author":"Liu","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2005.03.034_bib10","first-page":"207","article-title":"Intrahepatic cholestasis induced by drugs and chemicals","volume":"28","author":"Plaa","year":"1976","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2005.03.034_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/03602539709037578","article-title":"Neutrophil- and glutathione-mediated hepatotoxicity of alpha-naphthylisothiocyanate","volume":"29","author":"Roth","year":"1997","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bcp.2005.03.034_bib12","first-page":"412","article-title":"An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury","volume":"256","author":"Dahm","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2005.03.034_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/toxsci\/47.1.118","article-title":"Bile duct epithelial cells exposed to alpha-naphthylisothiocyanate produce a factor that causes neutrophil-dependent hepatocellular injury in vitro","volume":"47","author":"Hill","year":"1999","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bcp.2005.03.034_bib14","first-page":"243","article-title":"Nitric oxide and inducible nitric oxide synthase expression are downregulated in acute cholestasis in the rat accompanied by liver ischemia","volume":"127","author":"Baron","year":"2000","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.bcp.2005.03.034_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0742-8413(98)10018-X","article-title":"Liver damage induced by acute cholestasis in the rat is ameliorated partially by l-arginine","volume":"120","author":"Muriel","year":"1998","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.bcp.2005.03.034_bib16","first-page":"243","article-title":"Nitric oxide and inducible nitric oxide synthase expression are downregulated in acute cholestasis in the rat accompanied by liver ischemia","volume":"127","author":"Ozturk","year":"2000","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.bcp.2005.03.034_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1072-7515(03)00386-7","article-title":"The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia","volume":"197","author":"Brown","year":"2003","journal-title":"J Am Coll Surg"},{"issue":"Suppl","key":"10.1016\/j.bcp.2005.03.034_bib18","first-page":"719","article-title":"NCX-1000, a no-releasing derivative of UDCA, exerts anticholestatic effects in a rodent model of chronic cholangitis","volume":"36","author":"Fiorucci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2005.03.034_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00498250110102665","article-title":"Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL\/6 mouse","volume":"32","author":"Stinson","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2005.03.034_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bcp.2005.03.034_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/mol.65.1.130","article-title":"The liver-selective nitric oxide donor O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO\/NO) protects HepG2 cells against cytochrome P450 2E1-dependent toxicity","volume":"65","author":"Gong","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2005.03.034_bib22","doi-asserted-by":"crossref","first-page":"25823","DOI":"10.1074\/jbc.M112305200","article-title":"Nitric oxide ameliorates hydrophobic bile acid-induced apoptosis in isolated rat hepatocytes by non-mitochondrial pathways","volume":"277","author":"Gumpricht","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2005.03.034_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/toxsci\/kfg196","article-title":"Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes","volume":"75","author":"de Longueville","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bcp.2005.03.034_bib24","doi-asserted-by":"crossref","first-page":"G734","DOI":"10.1152\/ajpgi.00300.2003","article-title":"Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury","volume":"287","author":"Xu","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2005.03.034_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.niox.2005.01.005","article-title":"The nitric oxide prodrug, V-PYRRO\/NO, protects against cadmium toxicity and apoptosis at the cellular level","volume":"12","author":"Qu","year":"2005","journal-title":"Nitric Oxide"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T08:52:24Z","timestamp":1548492744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295205001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0006295205001814"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2005.03.034","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}